Skip to main content
Premium Trial:

Request an Annual Quote

Genome Therapeutics, Amgen Ink Drug-Discovery Pact

NEW YORK, Jan. 2 - Genome Therapeutics today said it will help Amgen discover and develop therapeutics for certain bone diseases.

 

While Genome Therapeutics would not detail the way it will work with the drug giant, the company stressed it will be a company-wide effort that will include its GenomeVision services and the human genetics department.

 

Genome Therapeutics will receive an undisclosed upfront payment, sponsored research funding, and stands to pocket milestones and "other downstream consideration" tied to the success of the collaboration.

 

Click here for more information.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.